drugset / Trial / NCT04656470

Neuroimaging Study of Dexmedetomidine-Induced Analgesia

NCT04656470

Phase 2/3 Completed 17 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelBasic science

Summary

Neuroimaging data will be collected for patients that are given low doses of dexmedetomidine in order to understand its analgesic effects.

Timeline

Start
2022-03-04
Primary completion
2025-05-27
Completion
2025-05-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg

Indications

No indication recorded.